WORLD Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma Thursday, May 21, 2026 · globenewswire Advertisement Read Original Article → Related Dispatches [CA] · Jul 5 LETTERS: July 5, 2026 [CA] · Jul 5 Column: Discover Lloydminster’s prized 1939 snow plane [US] · Jul 5 Horoscopes: Have you been fooling yourself? Neptune retrograde breaks the spell